CCACX
Price
$23.36
Change
-$0.25 (-1.06%)
Updated
Sep 20 closing price
VMCPX
Price
$352.79
Change
-$0.65 (-0.18%)
Updated
Sep 20 closing price
Ad is loading...

CCACX vs VMCPX

Header iconCCACX vs VMCPX Comparison
Open Charts CCACX vs VMCPXBanner chart's image
Calvert Mid-Cap C
Price$23.36
Change-$0.25 (-1.06%)
VolumeN/A
CapitalizationN/A
Vanguard Mid Cap Index InstitutionalPlus
Price$352.79
Change-$0.65 (-0.18%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
CCACX vs VMCPX Comparison Chart
Loading...
VS
CCACX vs. VMCPX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CCACX is a StrongBuy and VMCPX is a Buy.

FUNDAMENTALS
Fundamentals
VMCPX has more cash in the bank: 172B vs. CCACX (234M). VMCPX pays higher dividends than CCACX: VMCPX (1.51) vs CCACX (0.00). CCACX was incepted earlier than VMCPX: CCACX (30 years) vs VMCPX (14 years). CCACX is a more actively managed with annual turnover of: 27.00 vs. VMCPX (13.00). CCACX has a lower initial minimum investment than VMCPX: CCACX (1000) vs VMCPX (100000000). VMCPX annual gain was more profitable for investors over the last year : 25.17 vs. CCACX (21.39). VMCPX return over 5 years is better than : 56.93 vs. CCACX (-1.09).
CCACXVMCPXCCACX / VMCPX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence30 years14 years-
Gain YTD11.21112.59389%
Front LoadN/AN/A-
Min. Initial Investment10001000000000%
Min. Initial Investment IRAN/AN/A-
Net Assets234M172B0%
Annual Yield % from dividends0.001.51-
Returns for 1 year21.3925.1785%
Returns for 3 years-15.019.85-152%
Returns for 5 years-1.0956.93-2%
Returns for 10 years-21.72128.75-17%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ACHR3.060.01
+0.33%
Archer Aviation
SBT4.64-0.02
-0.43%
Sterling Bancorp
EBAY62.75-0.47
-0.74%
eBay
CNXC63.38-0.79
-1.23%
Concentrix Corp
NRBO3.19-0.07
-2.15%
NeuroBo Pharmaceuticals